​We are at the World Stroke Congress (WSC) in Abu Dhabi!

Moleac team was delighted to be part of the Stepping Out for Stroke 2024 walkathon, hosted by the Singapore National Stroke Association (SNSA).

Moleac is excited to announce a significant milestone in the journey of NeuroAiD II MLC901 as PT Ferron Par Pharmaceuticals will become our exclusive partner in Indonesia effective Jan 1ˢᵗ 2025.

We are thrilled to announce our participation at the World Stroke Congress (WSC) from October 23ʳᵈ to 26ᵗʰ, 2024, in Abu Dhabi.

Together with our distributor in Laos, Viengthong Med & Pharma, we held a successful scientific symposium on October 12 in Vientiane.

Together, we are #GreaterThan strokes! Moleac is excited to participate in the World Stroke Organization’s #GreaterThan Challenge this World Stroke Day! Our team is tracking physical activities and contributing to stroke prevention efforts.

STROKE STUDY HIGHLIGHTS – Cost-effectiveness of MLC601 in post-stroke functional recovery compared with placebo – the CHIMES & CHIMES-E studies by Chen CLH, Chai JH, Pokharkar YM, and Venketasubramanian N.

Moleac is honored to have sponsored the 20ᵗʰ Singapore International Stroke Conference, held from October 3-5, 2024 in Singapore.

A Memorable Symposium in Antalya! Last week in Antalya was truly inspiring, as we hosted a symposium that brought together neurology experts from Albania, Bulgaria, Croatia, Czech Republic, Macedonia, and Turkey.